Pharmaceutical companies typically use a variety of factors to determine the price of their drugs, including: Development and production costs: Pharmaceutical companies invest significant amounts of money into the research, development, and production of new drugs. The cost of these activities, including clinical trials and obtaining regulatory approval, is factored into the price of the drug. Marketing and Distribution Cost: Marketing and distribution costs may also be considered by pharmaceutical companies when determining drug prices. These costs include expenses related to advertising, sales representatives, and distribution networks. Drug Uniqueness: If a drug is the first of its kind or represents a significant improvement over existing treatments, the pharmaceutical company may set a higher price for it. If a drug has many competitors or is like existing treatments, the company may have to set a lower price to remain competitive. Market demand: Companies also consider the dem
Schedules: Schedule A, Schedule B, Schedule C, Schedule D, Schedule E1, Schedule F, Schedule G, Schedule H, Schedule H1, Schedule I, Schedule J, Schedule K, Schedule L1, Schedule M, Schedule M1, Schedule M2, Schedule M3, Schedule N, Schedule O, Schedule P, Schedule Q, Schedule R, Schedule S, Schedule T, Schedule U, Schedule V, Schedule W, Schedule X, Schedule Y
Schedule G describes the list of drugs:
Schedule G (Rule 97):
Schedule G describes the list of drugs:
- Aminopterin
- L-Asparaginase
- Bleomycin
- Busulphan; its salts
- Carbutamide Chlorambucil;its salts
- Chlorothiazide and other derivatives of 1, 2, 4 benzothiadiazine
- Chlorpropamide; its salts
- Chlorthalidone and other derivatives of Chlorobenzene compound
- Cis-Platin
- Cyclophosphamide; its salts
- Cytarabine
- Daunorubicin
- Di-Isopropyl Eluorophosphate
- Disodium Stilboestrol Diphosphate
- Doxorubicin Hydrochloride
- Ethacrynic Acid, its salts
- Ethosuximide
- Glibenclamide Hydantoin; its salts; its derivatives, their salts
- Hydroxyurea
- Insulin, all types
- Lomustine Hydrochloride
- Mannomustine; its salts
- Mercaptopurine; its salts
- Metformin; its salts
- Methsuximide
- Mustine, its salts
- Paramethadione
- Phenacemide
- Phenformin; its salts
- 5-Phenylhydantoin; its alkyl and aryl derivatives; its salts
- Primadone
- Procarpazine Hydrochloride
- Quinthazone
- Sarcolysine
- Sodium-2-Mercaptoethanesulfonate
- Tmoxiten Citrate
- Testolactone
- Thiotepa Tolbutamide
- Tretamine; its salts
- Troxidone
- Antihistaminic substances the following, their salts, their derivatives, salts of their derivatives
- Antazoline
- Bromodiphenhydramine
- Buclizine
- Chlorcyclizine
- Chlorpheniramine Clemizole
- Cyproheptadine
- Diphenhydramine
- Diphenylpyraline Doxylamine
- Succinate Isothipendyl
- Mebhydrolin Napadisylate
- Meclozine
- Phenindamine
- Pheniramine
- Promethazine
- Thenalidine
- Triprolidine
- Substances being tetra-N-Subs. derivatives of Ethylene Diamine or Prophylenediamine.
Note: Preparations containing the above substances excluding those intended for topical or external use are also covered by this Schedule
Labeling requirements:
If product contains a drug substance specified in Schedule G, be labeled with following words in legible black colored font size in completely red rectangular box:
SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under medical supervision
For more detail refer Drug and Cosmetic Act
Labeling requirements:
If product contains a drug substance specified in Schedule G, be labeled with following words in legible black colored font size in completely red rectangular box:
SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under medical supervision
For more detail refer Drug and Cosmetic Act
Comments
Post a Comment